Industry Roundup: Children's Rhinocort, MusclePharm Restructuring

Senators stir bulk caffeine criticism; AHPA updates membership process; Weiss heads Nutrition 21; and more news in brief.

Two senators frequently critical of FDA's regulation of dietary supplement manufacturing and marketing and a third member join the Center for Science in the Public Interest in asking the agency to ban retail sales of bulk powdered caffeine. “Despite several unintended and untimely deaths associated with powdered caffeine, the FDA has done little to regulate these products or adequately enforce the standards in place to protect Americans from the substantial risk associated with ingesting powdered caffeine in any form," Democrats Dick Durbin, IL, Richard Blumenthal, CT, and Sherrod Brown, OH, stated in an April 26 letter to FDA Commissioner Robert Califf. They added that "in the absence of strong regulatory action, companies are continuing to develop new delivery mechanisms and creative advertising ploys to attract new powdered caffeine users, and are doing so without relaying the serious health consequences of improper use." FDA in September submitted warning letters to five firms marketing bulk caffeine online, stating that the products “present a significant or unreasonable risk of illness or injury under the conditions of use recommended or suggested in the labeling" Also see "FDA Takes The Measure Of Bulk Caffeine In Warnings About Labels" - Pink Sheet, 7 September, 2015.. CSPI in 2014 submitted a citizen petition to FDA for a ban on bulk powdered caffeine; Durbin and Blumenthal noted the petition in a letter to the agency ([A#05150202002]).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

FTC Consumer Privacy Policy Driven By ‘Straw Man’ Arguments – Commissioner Holyoak

 

The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.

FTC’s New Commissioner ‘Dismayed’ By Agency Overreach

 

FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements. 

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

More from HBW Insight

Fragrance Industry Unification Hedges Against Tariff Impact – Experts

 

Fragrance companies and suppliers can draft contracts that ensure the cost burden of tariffs is shared, says attorney David Morrell of law firm Jones Day, during a recent panel discussion, ‘Tariffs in Motion: Insight for the Fragrance Industry.”

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By 

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By 

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.